[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-521508-105":59,"doc-detail-521508-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","m38-reference-method-for-broth-dilution-antifungal-susceptibility-testing-of-filamentous-fungi","M38 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","","CLSI standard M38—Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi sets out a reference approach for assessing antifungal susceptibility of filamentous fungi, including nondermatophyte and dermatophyte moulds, associated with invasive and/or cutaneous fungal infections. The standard covers antifungal agent selection, preparation of antifungal stock solutions and test dilutions, execution of the testing procedure, interpretation of results, and the purpose and implementation of quality control (QC) procedures, including manufacturer and user QC responsibilities. It also includes an overview of epidemiological cutoff values for selected Aspergillus spp. and species complexes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/m38-reference-method-for-broth-dilution-antifungal-susceptibility-testing-of-filamentous-fungi/521508/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/m38-reference-method-for-broth-dilution-antifungal-susceptibility-testing-of-filamentous-fungi/521508.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-10-07",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of CLSI M38 for filamentous fungi?","Question",{"text":113,"@type":114},"It provides a reference method to test antifungal susceptibility of filamentous fungi that cause invasive and/or cutaneous infections.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What steps does the standard cover for preparing and running tests?",{"text":118,"@type":114},"It addresses antifungal agent selection, preparation of antifungal stock solutions and dilutions, and implementation of the test procedure with result interpretation.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the standard treat quality control (QC)?",{"text":122,"@type":114},"It discusses the purpose and implementation of QC procedures, including responsibilities of both manufacturers and users for QC.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},521508,1791504129,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","3rd Edition  \nM38  \nReference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi  \nThis standard includes antifungal agent selection, preparation of antifungal stock solutions and dilutions for testing, test procedure implementation and interpretation, and quality control requirements for susceptibility testing of filamentous fungi (moulds) that cause invasive and cutaneous fungal infections.  \nA standard for global application developed through the Clinical and Laboratory Standards Institute consensus process.  \nLicensed to: Vandbergue Santos Pereira  \nThis document is protected by copyright. CLSI order \\#Ord-523206, Downloaded on 4/3/2020 .  \nClinical and Laboratory Standards Institute  \nSetting the standard for quality in medical laboratory testing around the world.  \nThe Clinical and Laboratory Standards Institute (CLSI) is a not-for-profit membership organization that brings together the varied perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: to foster excellence in laboratory medicine by developing and implementing medical laboratory standards and guidelines that help laboratories fulfill their responsibilities with efficiency, effectiveness, and global applicability.  \nConsensus Process  \nConsensus—the substantial agreement by materially affected, competent, and interested parties—is core to the development of all CLSI documents. It does not always connote unanimous agreement but does mean that the participants in the development of a consensus document have considered and resolved all relevant objections and accept the resulting agreement.  \nCommenting on Documents  \nCLSI documents undergo periodic evaluation and modification to keep pace with advances in technologies, procedures, methods, and protocols affecting the laboratory or health care.  \nCLSI’s consensus process depends on experts who volunteer to serve as contributing authors and/or as participants in the reviewing and commenting process. At the end of each comment period, the committee that developed the document is obligated to review all comments, respond in writing to all substantive comments, and revise the draft document as appropriate.  \nComments on published CLSI documents are equally essential and may be submitted by anyone, at any time, on any document. All comments are managed according to the consensus process by a committee of experts.  \nAppeal Process  \nWhen it is believed that an objection has not been adequately considered and responded to, the process for appeal, documented in the CLSI Standards Development Policies and Processes, is followed.  \nAll comments and responses submitted on draft and published documents are retained on file at CLSI and are available upon request.  \nGet Involved—Volunteer!  \nDo you use CLSI documents in your workplace? Do you see room for improvement? Would you like to get involved in the revision process? Or maybe you see a need to develop a new document for an emerging technology? CLSI wants to hear from you. We are always looking for volunteers. By donating your time and talents to improve the standards that affect your own work, you will play an active role in improving public health across the globe.  \nFor additional information on committee participation or to submit comments, contact CLSI.  \nClinical and Laboratory Standards Institute  \n950 West Valley Road, Suite 2500 Wayne, PA 19087 USA  \nP: +1.610.688.0100  \nF: +1.610.688.0700 [www.clsi.org](www.clsi.org)  \n[standard@clsi.org](standard@clsi.org)  \nLicensed to: Vandbergue Santos Pereira  \nThis document is protected by copyright. CLSI order \\#Ord-523206, Downloaded on 4/3/2020 .  \nM38, 3rd ed. November 2017 Replaces M38-A2  \nReference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi  \nBarbara D. Alexander, MD, MHS Gary W. Procop, MD, MS Philippe Dufresne, PhD (RMCCM)  \nAna Espinel-Ingroff, PhD, MS  \nJeff Fuller, PhD, FCCM, D(ABMM) Mahmoud A. Gh","cbCaik4gdQZSwYqt","https://ap.wps.com/l/cbCaik4gdQZSwYqt","pdf",3320170,62,"English","# Abstract\n## Scope and testing approach\n## QC procedures and responsibilities\n## Epidemiological cutoff values","[{\"question\":\"What is the purpose of CLSI M38 for filamentous fungi?\",\"answer\":\"It provides a reference method to test antifungal susceptibility of filamentous fungi that cause invasive and/or cutaneous infections.\"},{\"question\":\"What steps does the standard cover for preparing and running tests?\",\"answer\":\"It addresses antifungal agent selection, preparation of antifungal stock solutions and dilutions, and implementation of the test procedure with result interpretation.\"},{\"question\":\"How does the standard treat quality control (QC)?\",\"answer\":\"It discusses the purpose and implementation of QC procedures, including responsibilities of both manufacturers and users for QC.\"}]","M38 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi | PDF",1791408007,156]